Redwood Pharma AB presents at Stora Aktiedagen the 26th of November 2018
Martin Vidaeus, CEO at Redwood Pharma AB will present the company's latest developments at Stora Aktiedagen at the Sheraton Hotel in Stockholm on Monday the 26th of November at 13:20 CET in Sal 4. The presentation will be live streamed and can be followed at http://www.aktiespararna.se/tv/live.About RP101RP101 is the company’s lead program for the development of a novel treatment of chronic dry eye disease in postmenopausal women. The active substance is an endogenous small molecule already proven safe and effective in two Phase II clinical trials in the US. The active substance for